日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women

血管舒缩症状与绝经后妇女发生静脉血栓的风险

Harrington, L B; Blondon, M; Cushman, M; Kaunitz, A M; Allison, M A; Wang, L; Sullivan, S; Woods, N F; LaCroix, A Z; Heckbert, S R; McKnight, B; Rossouw, J; Smith, N L

Alcohol consumption and the risk of incident pulmonary embolism in US women and men

美国男女饮酒与肺栓塞发病风险的关系

Harrington, L B; Hagan, K A; Mukamal, K J; Kang, J H; Kim, J; Crous-Bou, M; Lindström, S; Rimm, E B; Kabrhel, C; Jensen, M K

Metabolomic analysis of 92 pulmonary embolism patients from a nested case-control study identifies metabolites associated with adverse clinical outcomes

一项嵌套病例对照研究对92例肺栓塞患者进行代谢组学分析,鉴定出与不良临床结局相关的代谢物。

Zeleznik, O A; Poole, E M; Lindstrom, S; Kraft, P; Van Hylckama Vlieg, A; Lasky-Su, J A; Harrington, L B; Hagan, K; Kim, J; Parry, B A; Giordano, N; Kabrhel, C

Reduction in physical function in women after venous thromboembolism

静脉血栓栓塞后女性身体机能下降

Hagan, K A; Harrington, L B; Kim, J; Zeleznik, O; Rimm, E B; Grodstein, F; Kabrhel, C

Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.

绝经后妇女内源性类固醇激素、性激素结合球蛋白和前体类固醇水平与止血因子水平的横断面关联

Harrington L B, Marck B T, Wiggins K L, McKnight B, Heckbert S R, Woods N F, LaCroix A Z, Blondon M, Psaty B M, Rosendaal F R, Matsumoto A M, Smith N L

The association of statin therapy with the risk of recurrent venous thrombosis

他汀类药物治疗与复发性静脉血栓形成风险之间的关联

Smith, N L; Harrington, L B; Blondon, M; Wiggins, K L; Floyd, J S; Sitlani, C M; McKnight, B; Larson, E B; Rosendaal, F R; Heckbert, S R; Psaty, B M

Differential associations of oral estradiol and conjugated equine estrogen with hemostatic biomarkers

口服雌二醇和结合雌激素与止血生物标志物的不同关联

Blondon, M; van Hylckama Vlieg, A; Wiggins, K L; Harrington, L B; McKnight, B; Rice, K M; Rosendaal, F R; Heckbert, S R; Psaty, B M; Smith, N L

Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy

NFE2L2/CYP3A5/ABO 对口服激素治疗相关静脉血栓形成风险的影响不显著

Blondon, M; Wiggins, K L; Harrington, L B; Psaty, B M; Smith, N L